Study of Tocotrienol Absorption and Distribution Under Different Fat Status
NCT ID: NCT01185769
Last Updated: 2010-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2009-09-30
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anti-Inflammatory Effect of Tocotrienol Supplementation in Subjects With Moderately Elevated Inflammation
NCT03532763
Effects of Tocotrienols Supplementation on Platelet Aggregation in Subjects With Metabolic Syndrome
NCT01631838
Acute Effects of Tocotrienols on Insulin Sensitivity and Metabolic Risk Markers in Individuals at Risk for Metabolic Syndrome
NCT01626430
Effect of Plant Stanols on Cholesterol Absorption
NCT00441857
Neuroprotective and Cardioprotective Effects Of Palm Vitamin E Tocotrienols
NCT00753532
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High fat
500 mg of tocotrienol will be administered at single dose after consumption of high fat diet
Tocotrienol
500 mg of tocotrienol will be administered after consumption of high fat diet
Low fat
500 mg of tocotrienol will be administered at single dose after consumption of low fat diet
Tocotrienol
500 mg of tocotrienol will be administered after consumption of low fat diet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tocotrienol
500 mg of tocotrienol will be administered after consumption of high fat diet
Tocotrienol
500 mg of tocotrienol will be administered after consumption of low fat diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* body mass index 18.5 \< X \< 30 kg/m2
* plasma cholesterol \< 5.2 mmol/L,
* TAG \< 1.7 mmol/L
Exclusion Criteria
* diabetic
* body mass index \< 18.5 or \> 30 kg/m2
* plasma cholesterol \> 5.2 mmol/L,
* TAG \> 1.7 mmol/L
* hypertension
* currently taking Vitamin E supplement
* current use of medication
* smoking.
22 Years
25 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Malaya
OTHER
Malaysia Palm Oil Board
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Malaysian Palm Oil Board
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Weng-Yew Wong, Bsc
Role: PRINCIPAL_INVESTIGATOR
Malaysia Palm Oil Board
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Malaysian Palm Oil Board
Bangi, Selangor, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PD141/09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.